Cargando…
The potential adjunctive benefit of adding metformin to standard treatment in inoperable cancer patients: a meta-analysis of randomized controlled trials
BACKGROUND: Recently, there have been several randomized clinical trials (RCTs) conducted to evaluate the efficacy and safety of metformin plus standard treatment in inoperable cancer patients. Our meta-analysis aimed to assess the efficacy of metformin in combination with standard treatment in inop...
Autores principales: | Wu, Zhonghua, Qu, Bicheng, Huang, Xuanzhang, Song, Yongxi, Gao, Peng, Shi, Jinxin, Zhou, Cen, Wang, Zhenning |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7723600/ https://www.ncbi.nlm.nih.gov/pubmed/33313149 http://dx.doi.org/10.21037/atm-20-4441 |
Ejemplares similares
-
Conversion Surgery for Stage IV Gastric Cancer
por: Zhang, Fei, et al.
Publicado: (2019) -
The Potential Effect of Metformin on Cancer: An Umbrella Review
por: Yu, Hong, et al.
Publicado: (2019) -
The efficacy of adding targeted agents to neoadjuvant therapy for locally advanced rectal cancer patients: a meta‐analysis
por: Zhong, Xi, et al.
Publicado: (2018) -
Statin use and its potential therapeutic role in esophageal cancer: a systematic review and meta-analysis
por: Zhou, Cen, et al.
Publicado: (2019) -
The tRNA-Derived Fragment-3017A Promotes Metastasis by Inhibiting NELL2 in Human Gastric Cancer
por: Tong, Linhao, et al.
Publicado: (2021)